AYALA PHARMACEUTICALS, INC.: cashflow_financing

Value{"amount": 42862254, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2002-03-01 – 2013-07-31
Statuscurrent
EntityAYALA PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001144204-13-050970 · Open the official SEC filing →
Retrieved: 2026-08-19T11:01:28.181425+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001100397/cashflow-financing/2013-07-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/5522d3a2-8d2c-47f8-8aae-0ecc44e30247

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies